The ESGENA (European Society of Gastroenterology and Endoscopy Nurses and Associates) Conference in Barcelona was timed in conjunction with the UEG (United European Gastroenterology) Week, in order to provide an additional learning opportunity for all those attending. The Week brings together practitioners, nurses, suppliers and other stakeholders in the field of Gastroenterology.
Last week , John Dempster – business development manager at TforG – attended the ESGENA Conference. John has more than 15 years experience in the medical device sector. His focus is on understanding the trends in MedTech device markets and to increase internal knowledge. In this interview with the TforG editorial team, he shares some of this experience and his insights with us.
What was your objective for being present at ESGENA?
The aim was to get an understanding of what was happening in the market place of gastroenterology, and endoscopy, especially in terms of what the new rising technologies are innovations.
What trends and innovations did you see at the conference exhibitions and presentations?
There is an interesting development in the field of remote imaging of the intestinal tract. At least three to four companies at the conference were working in this field, such as CapsoVision and GivenImaging (Medtronic); it is a market that is clearly showing growth, accompanied by a gradual trend away from traditional endoscopic treatments.
TforG estimates that the EU Big 5 market, including most of the major endoscopic procedures, enumerates 4.8m-5.2m procedures annually. These procedures are expected to increase by 5.5% in the next 5 years.
Currently around 4% of this market is applying innovative new technologies.
The particular procedural market that would benefit from capsule technology (which is included as such an innovative technology) is between 3-5% of all endoscopic procedures.
Capsule technology is gradually gaining footing and penetrating the market as it is the most minimally invasive device available for endoscopic diagnostics.
The big players on the market at the moment, particularly in Europe, are EndoCapsule (Olympus), PillCam (GivenImaging), MiroCam (IntroMedic), OMOM (Jinshan Science and Technology Company) and CapsoCam (CapsoVision).
A different company present at the Conference, SmartMedical Systems, showed add-on hardware for visualizing and enhancing existing gastroenterological techniques. SmartMedical offer a multi-adaptable device that fits onto the current technology of many other and differing brands, thereby essentially opening up limitless possibilities to work with other companies.
Interesting to note, this year’s conference drew a substantial Asian audience, showing a trend of the growing attention to and reputation of the event itself, and of course, that of European technology and innovation.
TforG estimates that the worldwide gastrointestinal endoscopy diagnostic and therapeutic market in 2015 is valued around €5.6 bn. The overall growth rate of this field is expected to remain flat. However, the Irritable Bowel Syndrome (IBS) therapy market is estimated to increase by 10% in the next four years, Ulcerative Colitis by 4.3% and Crohn’s Disease by 4.7%.
To learn more about volumes of specific gastroenterology procedures in various country markets, please have a look at the TforG Surgical Procedure Volumes in our Business Intelligence Store. Also recently made available are the Surgical Procedure Volumes for the Big 5.